Please login to the form below

Not currently logged in

Takeda expands into Brazil

Takeda, Japan's largest drug company, has announced it is to establish a commercial subsidiary in Brazil

Takeda, Japan's largest drug company, has announced it is to establish a commercial subsidiary in Brazil.

The new operation, which will be based in Sao Paulo, will import and commercialise Takeda products for the Brazilian market.

This latest expansion by the Japanese company is the twelfth in as many months following the establishment of subsidiaries in Belgium, Canada, Denmark, Ireland, Luxembourg, Mexico, Norway, Portugal, Spain, Sweden and Turkey.

"Combined with Takeda's additional recent expansions, this opportunity will drive Takeda's ability to maximise the potential of our pipeline in Brazil," said Alan MacKenzie, executive vice president international operations, Takeda Pharmaceuticals International.

"Brazil is an important country in the Latin American region for Takeda to ensure we are providing our products where patients need them."

With a population of around 196 million people, Brazil is the largest country in Latin America and accounts for more than 40 per cent of pharmaceutical sales in the region. Pharmaceutical sales in the country are forecast to grow by 8.5 per cent each year until 2013.

2nd December 2009


Featured jobs

Subscribe to our email news alerts


Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....